Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cns Pharmaceuticals Inc (NQ: CNSP ) 0.1950 +0.0220 (+12.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 6,091,197 Open 0.1800 Bid (Size) 0.1910 (17) Ask (Size) 0.2000 (2) Prev. Close 0.1730 Today's Range 0.1692 - 0.2029 52wk Range 0.0955 - 137.50 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment August 22, 2024 Via Investor Brand Network CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment August 22, 2024 Via ACCESSWIRE Performance YTD -99.67% -99.67% 1 Month -82.74% -82.74% 3 Month -98.10% -98.10% 6 Month -98.45% -98.45% 1 Year -99.79% -99.79% More News Read More Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer August 21, 2024 Via Investor Brand Network BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results August 15, 2024 Via Investor Brand Network Exposures Product Safety CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024 August 15, 2024 Via InvestorPlace CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results August 15, 2024 Via ACCESSWIRE What's Going On With CNS Pharmaceuticals Stock Tuesday? July 30, 2024 Via Benzinga CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series July 16, 2024 Via ACCESSWIRE Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket August 06, 2024 Via Benzinga Study Uncovers How Brain Tumors Evolve During Treatment August 05, 2024 Via Investor Brand Network Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket August 05, 2024 Via Benzinga Microsoft Office Outage: Microsoft Investigates Applications, Services Issue July 30, 2024 Via InvestorPlace Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 30, 2024 Via Benzinga SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis July 30, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today? July 30, 2024 Via InvestorPlace BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM July 30, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Dow Jumps 200 Points; Pfizer Earnings Top Views July 30, 2024 Via Benzinga Topics Stocks Exposures US Equities CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies July 30, 2024 Via ACCESSWIRE BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CMO to Present Poster at Upcoming SNO/ASCO CNS Cancer Conference July 25, 2024 Via Investor Brand Network CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference July 25, 2024 Via ACCESSWIRE Study Uncovers Ancient Egyptian Attempts to Surgically Remove Brain Cancer July 22, 2024 Via Investor Brand Network BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series July 16, 2024 Via Investor Brand Network Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday July 11, 2024 Via InvestorPlace Research Identifies How Glioblastoma Develops Resistance to Immunotherapy July 08, 2024 Via Investor Brand Network BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M July 05, 2024 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.